PLX Chart
See on advanced chart >
About
Protalix BioTherapeutics, Inc. and its wholly-owned subsidiary, Protalix Ltd., are biopharmaceutical companies focused on the development and commercialization of recombinant therapeutic proteins based on the Company's proprietary ProCellEx protein expression...
Read More
- HighlightA biopharmaceutical company that develops recombinant therapeutic proteins
- ExchangeAMEX
- Listing Date03/12/2007
- Established DateInvalid Date
- Full-time Employees193
- Address2 University Plaza Suite 100 Hackensack NJ 07601
- Tel1-201-6969345
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology
